Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Outlook Therapeutics (OTLK) over the last 8 years, with Q4 2025 value amounting to $346111.0.

  • Outlook Therapeutics' Other Non-Current Assets fell 1679.5% to $346111.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $346111.0, marking a year-over-year decrease of 1679.5%. This contributed to the annual value of $417523.0 for FY2025, which is N/A changed from last year.
  • As of Q4 2025, Outlook Therapeutics' Other Non-Current Assets stood at $346111.0, which was down 1679.5% from $417523.0 recorded in Q3 2025.
  • Outlook Therapeutics' Other Non-Current Assets' 5-year high stood at $464388.0 during Q2 2025, with a 5-year trough of $346111.0 in Q4 2025.